There were nearly 290,000 separate visits to the UK NSC's 3 online platforms during 2023, reflecting the committee's ongoing commitment to continually improve its stakeholder engagement.
The UK NSC has held the inaugural meeting of the partnership board which will oversee the development of the in-service evaluation of newborn screening for spinal muscular atrophy in real world NHS services.
We have published updated information on paid-for commercial screening tests and how they differ from quality-assured end-to-end NHS screening programmes
The UK NSC has updated its guidance and processes for individuals working with the committee to declare any interests that may conflict, or be perceived to conflict, with that work.
The UK NSC has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.
Three chapters added to UK NSC screening in healthcare manual which gives an overview of best practice for implementing health screening programmes anywhere in the world.
UK NSC survey results give big thumbs-up to blog and constructive feedback on web pages.
Nearly 100 people logged on to the second UK NSC web-based seminar, which focused on planning and implementing an in-service evaluation.
The UK NSC is very excited by the news, announced on International Men’s Day, of a major new prostate cancer screening trial backed by £42 million of funding from Prostate Cancer UK and the government.
Please complete a short survey to help us make sure the UK NSC web pages are fit for purpose and meet the needs of all our stakeholders.
More than 90 stakeholders attended the UK NSC's first online seminar on the development of a clinical pathway for the modelling of targeted lung cancer screening.